Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia

PURPOSE: Chemotherapy drug resistance and relapse of the disease have been the major factors limiting the success of acute myeloid leukemia (AML) therapy. Several factors, including the pharmacokinetics (PK) of Cytarabine (Ara-C) and Daunorubicin (Dnr), could contribute to difference in treatment ou...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Chemother Pharmacol
Main Authors: Varatharajan, Savitha, Panetta, John C., Abraham, Ajay, Karathedath, Sreeja, Mohanan, Ezhilpavai, Lakshmi, Kavitha M., Arthur, Nancy, Srivastava, Vivi M., Nemani, Sandeep, George, Biju, Srivastava, Alok, Mathews, Vikram, Balasubramanian, Poonkuzhali
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7115946/
https://ncbi.nlm.nih.gov/pubmed/27738808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-016-3166-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares